Organ-targeted intravenous (IV) delivery of polymeric nanoparticles (NPs) remains a translational drug delivery challenge, as an overwhelming fraction of the administered dose is typically cleared due to fouling at the nano-bio interface. As a solution, we hav... ...

请注册登录后继续浏览